ReviewCurrent cardiology reports2021
Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19.
Review in Current cardiology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Cardiovascular effects of the post-COVID-19 condition.Nature cardiovascular research · 2024Review
- Cardiac magnetic resonance T2* mapping in patients with COVID-19 pneumonia is associated with serum ferritin level?The international journal of cardiovascular imaging · 2023Article
- Ultrasound during the COVID-19 Pandemic: A Global Approach.Journal of clinical medicine · 2023Review
- Physicians' perceptions on the impact of COVID-19 in coronary artery disease diagnostic imaging and treatment: A Latin America survey. For the Society of Cardiovascular Imaging of the Inter-American Society of Cardiology.International journal of cardiology. Heart & vasculature · 2022Article
- Role of Cardiac Imaging Modalities in the Evaluation of COVID-19-Related Cardiomyopathy.Diagnostics (Basel, Switzerland) · 2022Review
- Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2.BMC cardiovascular disorders · 2022Review
- Editorial for "Cardiac Magnetic Resonance Imaging Findings in 2,954 COVID-19 Adult Survivors: A Comprehensive Systematic Review".Journal of magnetic resonance imaging : JMRI · 2022Article
- A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis.Diagnostics (Basel, Switzerland) · 2022Review
- Chest Computed Tomography Is an Efficient Method for Initial Diagnosis of COVID-19: An Observational Study.Frontiers in medicine · 2022Article
- Improving risk prediction for pulmonary embolism in COVID-19 patients using echocardiography.Pulmonary circulation · 2022Article
- COVID-19 and Myocarditis: Review of Clinical Presentations, Pathogenesis and Management.Heart international · 2022Review
- The Evolving Role of Echocardiography During the Coronavirus Disease 2019 Pandemic.Heart international · 2022Review
- COVID-19: The Impact on Cardiovascular System.Biomedicines · 2021Review
- COVID and Cardiovascular Disease: What We Know in 2021.Current atherosclerosis reports · 2021Review
- Impact of COVID-19 on Workload and Workflow in Echocardiography Unit in a Tertiary Care University Hospital: A Monocentric Observational Study.Heart views : the official journal of the Gulf Heart AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purpose of reviewA growing number of cardiovascular manifestations resulting from the novel SARS-CoV-2 coronavirus (COVID-19) have been described since the beginning of this global pandemic. Acute myocardial injury is common in this population and is associated with higher rates of morbidity and mortality. The focus of this review centers on the recent applications of multimodality imaging in the diagnosis and management of COVID-19-related cardiovascular conditions. RECENT
findingsIn addition to standard cardiac imaging techniques such as transthoracic echocardiography, other modalities including computed tomography and cardiac magnetic resonance imaging have emerged as useful adjuncts in select patients with COVID-19 infection, particularly those with suspected ischemic and nonischemic myocardial injury. Data have also emerged suggesting lasting COVID-19 subclinical cardiac effects, which may have long-term prognostic implications. With the spectrum of COVID-19 cardiovascular manifestations observed thus far, it is important for clinicians to recognize the role, strengths, and limitations of multimodality imaging techniques in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.